science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.1004562 on August 4, 2005

Published online before print August 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1004562v1
78/5/1060    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boudewijns, M.
Right arrow Articles by Bossuyt, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boudewijns, M.
Right arrow Articles by Bossuyt, X.
(Journal of Leukocyte Biology. 2005;78:1060-1069.)
© 2005 by Society for Leukocyte Biology

Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides

Michaël Boudewijns*, Axel Jeurissen*, Margaretha Wuyts*, Leen Moens*, Louis Boon{dagger}, Joost J. Van Neerven{dagger}, Ahmad Kasran{ddagger}, Lut Overbergh§, Caroline Lenaerts, Marc Waer, Chantal Mathieu§, Jan L. Ceuppens{ddagger} and Xavier Bossuyt*,1

* Experimental Laboratory Medicine, Department of Molecular Cell Biology, and Laboratories of
{ddagger} Experimental Immunology, Department of Pathophysiology,
§ Experimental Medicine and Endocrinology (LEGENDO), and
Experimental Transplantation, Faculty of Medicine, Catholic University Leuven, Belgium; and
{dagger} Bioceros, B.V., Amsterdam, The Netherlands

1Correspondence: Experimental Laboratory Medicine, Department of Molecular Cell Biology, Faculty of Medicine, Catholic University Leuven, U.Z. Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. E-mail: Xavier.bossuyt{at}uz.kuleuven.ac.be

The capsular polysaccharides (caps-PS) of Streptococcus pneumoniae are classified as thymus-independent antigens. Nevertheless, T lymphocytes can modulate the antibody response to caps-PS. In this study, we show that anticytotoxic T lymphocyte-associated antigen 4 (CTLA-4) treatment, along with administration of caps-PS to BALB/c mice, resulted in a dose-dependent generation of a strong caps-PS-specific antibody response. Anti-CTLA-4 treatment had no effect on the immunoglobulin G (IgG) antibody production in athymic nu/nu mice. Anti-CTLA-4 treatment stimulated the IgG antibody production in severe combined immunodeficiency (SCID)/SCID mice reconstituted with CTLA-4–/– B lymphocytes and wild-type T lymphocytes. This excluded the possibility that anti-CTLA-4 enhanced antibody production by direct interaction with B lymphocytes. Anti-CTLA-4 treatment enhanced the antibody production in SCID/SCID mice reconstituted with B lymphocytes and CD4(+) and CD8(+) T lymphocytes but not in SCID/SCID mice reconstituted with B lymphocytes in the absence of CD4(+) and/or CD8(+) cells. Administration of anti-CTLA-4 in BALB/c mice but not in nu/nu mice resulted in a markedly increased production of interleukin (IL)-2, IL-4, and interferon-{gamma}. Taken together, these data strongly suggest a role of T lymphocytes and CTLA-4 in the regulation of the antibody response to caps-PS.

Key Words: Streptococcus pneumoniae • T lymphocytes




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
L. Moens, A. Jeurissen, R. S. Mittler, G. Wuyts, G. Michiels, L. Boon, J. L. Ceuppens, and X. Bossuyt
Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae
J. Leukoc. Biol., September 1, 2007; 82(3): 638 - 644.
[Abstract] [Full Text] [PDF]